India’s race towards Viksit Bharat 2047 is increasingly defined by whether healthcare can be accessible, affordable, and equitable, driving investment, innovation, and reform that prioritise both capacity and fairness amid rising costs and technological opportunities.
India’s march towards its Viksit Bharat 2047 ambition is increasingly being judged not only by growth and infrastructure, but by whether families can still afford to see a doctor without fear of financial shock. That is the central warning running through recent commentary on the country’s health sector: expansion alone is not enough if access remains uneven and treatment still pushes households into debt. According to Grant Thornton India, the bigger challenge has shifted from access alone to access plus outcomes, with governance and responsible use of technology now central to sustainable reform.
That concern is rooted in hard numbers. The National Health Accounts Estimates for 2022-23 showed out-of-pocket spending still accounting for 43.4% of total health expenditure, while older research published on PubMed found that roughly 80% of healthcare costs in India are paid privately and that hospital bills push millions of households below the poverty line each year. Taken together, those figures underline a system in which illness can still become a financial crisis.
The pressure is set to intensify. EY-Parthenon, in a report covered by the Financial Express, projected that India’s healthcare spending could rise seventeen-fold by 2047 to ₹190 lakh crore as the population ages and non-communicable diseases become more common. PwC India’s outlook for 2047 also places healthcare at the centre of a much richer, more services-led economy, suggesting that the sector will need far greater scale, better policy support and sharper execution to keep pace with national growth.
Investors are already treating the market as a major opportunity. The India Brand Equity Foundation says the hospital market was worth US$98.98 billion in 2023 and is expected to grow at an annual rate of 8.0% through 2032. But the investment case is increasingly tied to whether companies can deliver more than premium care in large cities. Affordability, transparency and trust are becoming commercial as well as social tests.
That is where technology may play a bigger role. Grant Thornton argues that artificial intelligence can help improve service delivery and patient outcomes, but only if it is paired with strong oversight and disciplined governance. In practice, that means using digital tools to reduce friction in appointments, diagnostics, claims and follow-up care, while avoiding the kind of opaque billing and poor communication that erode confidence.
For hospitals, insurers and health-tech companies, the message is clear: growth built only on high-ticket care may be less durable than models that can serve Tier 2 and Tier 3 markets at lower cost. Businesses that improve pricing clarity, simplify claims and expand access to preventive and chronic care management are likely to be better positioned as regulation tightens and medical inflation remains elevated.
India’s healthcare story is therefore no longer just about capacity. It is about whether the system can become both larger and fairer at the same time. A stronger sector can be an engine of investment and innovation, but it will also be judged by a simpler standard: whether ordinary people can get treatment without being forced to choose between their health and their finances.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
